YUM—You missed the point of the WSJ article, evidently. The problem is not that a P/E ratio of 19 is too high for a growth rate of 12.6%, but rather that the WSJ doesn’t think the consesus growth rate for YUM is realistic.
p.s. I get your reference to the Biotech Values thread on the PEG ratio.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”